Pleural Mesotheliomas Completed Phase 1 Trials for Decitabine (DB01262)

Also known as: Pleural Mesothelioma

IndicationStatusPhase
DBCOND0029910 (Pleural Mesotheliomas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00037817Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural MalignanciesTreatment